← Back to Search

Home Telemonitoring for Heart Attack

N/A

Waitlist Available

Led By Joerg Herrmann, MD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Acute myocardial infarction, both STEMI and non-STEMI

Able to use the home ECG telemonitoring

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 days after hospital discharge

Awards & highlights

Study Summary

This trial is testing a new way to monitor heart health using a portable device and phone call follow-ups. They hope it will improve patient outcomes and reduce ER visits and hospital readmissions.

Who is the study for?

This trial is for heart attack survivors who can use a home ECG telemonitoring device, have a smartphone with internet to transmit data, and support from a family member. It's not for those without app access, unable to follow instructions, in nursing homes or with certain medical conditions like uninterpretable ECGs.Check my eligibility

What is being tested?

The study tests if using the SmartHeart portable ECG device and phone follow-ups can better detect heart issues early on and reduce emergency visits compared to usual care after a heart attack.See study design

What are the potential side effects?

Since this trial involves monitoring rather than medication, direct side effects are minimal but may include discomfort or skin irritation from the device or anxiety due to health status awareness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had a heart attack recently.

Select...

I can use a home ECG monitoring device.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 days after hospital discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 days after hospital discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days after hospital discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Emergency Room Visits

Major Adverse Cardiovascular Events

Mortality rate

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SmartHeart Device GroupExperimental Treatment1 Intervention

In addition to routine cardiac treatment, participants will wear the SmartHeart device

Group II: Control (standard treatment) GroupActive Control1 Intervention

Participants will receive routine cardiac treatment

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,205 Previous Clinical Trials

3,766,544 Total Patients Enrolled

Joerg Herrmann, MDPrincipal Investigator - Mayo Clinic

Mayo Clinic

2 Previous Clinical Trials

200 Total Patients Enrolled

Media Library

SmartHeart Device Clinical Trial Eligibility Overview. Trial Name: NCT04664881 — N/A

Heart Attack Research Study Groups: Control (standard treatment) Group, SmartHeart Device Group

Heart Attack Clinical Trial 2023: SmartHeart Device Highlights & Side Effects. Trial Name: NCT04664881 — N/A

SmartHeart Device 2023 Treatment Timeline for Medical Study. Trial Name: NCT04664881 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrollment of participants in this trial?

"Affirmative. Per the information found on clinicaltrials.gov, this study is currently in search of applicants and launched on October 14th 2020. The total number of patients needed amounts to 240 and will be recruited from a single medical centre."

Answered by AI

Is it feasible for individuals to sign up now for this medical experiment?

"Confirmation of this can be found on clinicaltrials.gov, where the trial is documented to have been first posted in October 14th 2020 and edited most recently on February 17th 2022. It appears that recruitment for patients is still ongoing."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Home Telemonitoring In Patients After Myocardial Infarction

Joerg Herrmann, MD 2020. "Home Telemonitoring In Patients After Myocardial Infarction". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04664881.

All > Heart Attack